Gary S. Hoffman

Active 1980–2022

93
Papers
29,005
Citations
81
h-index
93
i10-index

Citations

Citations per year for Gary S. Hoffman1974: 1 citations1978: 3 citations1980: 1 citations1984: 1 citations1985: 1 citations1986: 1 citations1987: 1 citations1990: 2 citations1991: 5 citations1992: 10 citations1993: 14 citations1994: 21 citations1995: 55 citations1996: 48 citations1997: 68 citations1998: 73 citations1999: 84 citations2000: 114 citations2001: 97 citations2002: 119 citations2003: 122 citations2004: 117 citations2005: 132 citations2006: 134 citations2007: 144 citations2008: 156 citations2009: 109 citations2010: 199 citations2011: 166 citations2012: 192 citations2013: 192 citations2014: 173 citations2015: 188 citations2016: 182 citations2017: 192 citations2018: 175 citations2019: 562 citations2020: 538 citations2021: 471 citations2022: 382 citations2023: 248 citations2024: 388 citations2025: 175 citations2026: 1 citations1975–1977: no citations, so these years are not shown1979: no citations, so this year is not shown1981–1983: no citations, so these years are not shown1988–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,214 citing papers, 22.1% of this breakdownUnited Kingdom: 573 citing papers, 10.4% of this breakdownFrance: 411 citing papers, 7.5% of this breakdownGermany: 376 citing papers, 6.8% of this breakdownItaly: 321 citing papers, 5.8% of this breakdownNetherlands: 252 citing papers, 4.6% of this breakdownCanada: 212 citing papers, 3.9% of this breakdownChina: 202 citing papers, 3.7% of this breakdownSpain: 202 citing papers, 3.7% of this breakdownJapan: 198 citing papers, 3.6% of this breakdownSweden: 123 citing papers, 2.2% of this breakdownAustria: 100 citing papers, 1.8% of this breakdown
0%22.1%Other 23.9%

Fields

  • Medicine90.4%
  • Immunology and Microbiology5.5%
  • Biochemistry, Genetics and Molecular Biology3.4%
  • Neuroscience0.4%
  • Computer Science0.1%
  • Other0.2%

Topics

  • Vasculitis and related conditions23.5%
  • Otitis Media and Relapsing Polychondritis6.7%
  • Systemic Sclerosis and Related Diseases4.4%
  • Renal Diseases and Glomerulopathies4%
  • Systemic Lupus Erythematosus Research3.7%
  • Sarcoidosis and Beryllium Toxicity Research3.3%
  • Other54.4%

Coauthors

All papers

Open in search
  1. Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2010 cited by 2,726

  2. Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John H. Stone - New England Journal of Medicine 2013 cited by 727

  3. A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell Arteritis

    Authors: , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2017 cited by 392

  4. Takayasu Arteritis

    Authors: , , , , , , - Annals of Internal Medicine 1994 cited by 1,624

  5. Wegener Granulomatosis: An Analysis of 158 Patients

    Authors: , , , , , , , - Annals of Internal Medicine 1992 cited by 2,873

  6. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2015 cited by 263

  7. Nomenclature of Systemic Vasculitides

    Authors: , , , , , , , , , , , , , , , - Arthritis & Rheumatism 1994 cited by 3,850

  8. Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study

    Authors: , , , , , , , , , , , , , - The Journal of Rheumatology 2015 cited by 187

  9. Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ulrich Specks, Robert Spiera, Antoine G. Sreih, E. William St. Clair, John H. Stone, Steven R. Ytterberg, James T. Elder, Jia Qu, Toshiki Ochi, Naoto Hirano, Jeffrey C. Edberg, Ronald J. Falk, Christopher I. Amos, Katherine A. Siminovitch - Arthritis & Rheumatology 2016 cited by 178

  10. Neutrophil‐Related Gene Expression and Low‐Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

    Authors: , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2015 cited by 137

  11. Patterns of Arterial Disease in Takayasu Arteritis and Giant Cell Arteritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Arthritis Care & Research 2019 cited by 125

  12. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.

    Authors: , , , , , , , , , - 2007 cited by 563

  13. A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score

    Authors: , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatism 2001 cited by 466

  14. A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard A. Prayson, Raashid Luqmani, George Nuki, Euan McRorie, Yvonne Sherrer, Shawn Baca, B Walsh, Diane Ferland, Martin Soubrier, Hyon K. Choi, Wolfgang L. Gross, A Segal, Charles Ludivico, Xavier Puéchal, International Network for the Study of Systematic Vasculitides (INSSYS) - Arthritis & Rheumatism 2002 cited by 576

  15. A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jan Henrik Schirmer, Frank Moosig, Verena Schönau, André Franke, Øyvind Palm, Øyvind Molberg, Andreas P. Diamantopoulos, Simon Carette, David Cuthbertson, Lindsy Forbess, Gary S. Hoffman, Nader Khalidi, Curry L. Koening, Carol A. Langford, Carol A. McAlear, Larry W. Moreland, Paul A. Monach, Christian Pagnoux, Philip Seo, Robert Spiera, Antoine G. Sreih, Kenneth J. Warrington, Steven R. Ytterberg, Peter K. Gregersen, Colin Pease, Andrew Gough, Michael R. Green, Lesley Hordon, Stephen Jarrett, Richard A. Watts, Sarah Levy, Yusuf Patel, Sanjeet Kamath, Bhaskar DasGupta, Jane Worthington, Bobby P. C. Koeleman, Paul I. W. de Bakker, Jennifer H. Barrett, Carlo Salvarani, Peter A. Merkel, Miguel Á. González‐Gay, Ann W Morgan, Javier Martı́n, Agustín Martínez-Berriochoa, Ainhoa Unzurrunzaga, Ana Hidalgo-Conde, Ana Belén Madroñero-Vuelta, Antonio Fernández‐Nebro, M. Carmen Ordóñez-Cañizares, B. Escalante, Begoña Marí-Alfonso, B. Sopeña, César Magro, Enrique Raya, Elena Grau, José A. Ruiz San Román, Eugenio de Miguel, FJ López-Longo, Lina Martínez, Carmen Gómez‐Vaquero, Benjamín Fernández‐Gutiérrez, Luis Rodríguez‐Rodríguez, J. Bernardino Díaz-López, Luis Caminal‐Montero, Aleida Martínez Zapico, Jordi Monfort, Laura Tío, Julio Sánchez-Martín, Juan José Alegre Sancho, Luís Sáez-Comet and 11 more - The American Journal of Human Genetics 2015 cited by 178

  16. Rituximab Versus Cyclophosphamide for ANCA-Associated Vasculitis with Renal Involvement

    Authors: , , , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2014 cited by 177

  17. Identification of Multiple Genetic Susceptibility Loci in Takayasu Arteritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenneth J. Warrington, Mehmet Akif Öztürk, Steven R. Ytterberg, Veli Çobankara, Ahmet Mesut Onat, Joel M. Guthridge, Judith A. James, Şevket Ercan Tunç, Nurşen Düzgün, Müge Bıçakçıgil, Sibel P. Yentür, Peter A. Merkel, Haner Di̇reskeneli̇, Amr H. Sawalha - The American Journal of Human Genetics 2013 cited by 174

  18. Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3

    Authors: , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2016 cited by 170

  19. Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome‐Wide Association Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mehmet Akif Öztürk, Ayten Yazıcı, Ayşe Çefle, Ahmet Mesut Onat, Bünyamin Kısacık, Christian Pagnoux, Timuçin Kaşifoğlu, Emire Seyahi, İzzet Fresko, Philip Seo, Antoine G. Sreih, Kenneth J. Warrington, Steven R. Ytterberg, Veli Çobankara, Deborah S. Cunninghame‐Graham, Timothy J. Vyse, Ömer Nuri̇ Pamuk, Şevket Ercan Tunç, Ediz Dalkılıç, Müge Bıçakçıgil, Sibel P. Yentür, Jonathan D. Wren, Peter A. Merkel, Haner Di̇reskeneli̇, Amr H. Sawalha - Arthritis & Rheumatology 2015 cited by 104

  20. A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Takayasu Arteritis

    Authors: , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2017 cited by 165

  21. Interpretation of Head and Neck Biopsies in Wegenerʼs Granulomatosis

    Authors: , , , , , - The American Journal of Surgical Pathology 1990 cited by 368

  22. Damage caused by Wegener's granulomatosis and its treatment: Prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)

    Authors: , , , , , , , , , , , , , - Arthritis & Rheumatism 2005 cited by 204

  23. Myeloperoxidase–Antineutrophil Cytoplasmic Antibody (ANCA)–Positive and ANCA‐Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets

    Authors: , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2016 cited by 105

  24. Giant Cell Arteritis

    Authors: - Annals of Internal Medicine 2016 cited by 87